News for Idera Pharmaceuticals Inc - Google Finance

IDERA PHARMACEUTICALS INC : Idera Announces Presentation of Positive ...

Wed, 08 May 2013 11:26:41 GMT

IDERA PHARMACEUTICALS INC : Idera Announces Presentation of Positive ...
4-traders (press release) - May 8, 2013

Idera Pharmaceuticals (NASDAQ: IDRA) today announced presentation of data from its randomized, double-blind, placebo-controlled Phase 2 trial that showed improvements from baseline of up to 90% in Psoriasis Area Severity Index (PASI) scores in ...

IDERA PHARMACEUTICALS INC : Idera Pharmaceuticals Reports First Quarter ...

Wed, 15 May 2013 12:23:44 GMT

IDERA PHARMACEUTICALS INC : Idera Pharmaceuticals Reports First Quarter ...
4-traders (press release) - May 15, 2013

"Our next objective in Idera's autoimmune disease program is to initiate a Phase 2 study of IMO-8400, a first-in-class TLR7, 8 and 9 antagonist, in patients with moderate-to-severe plaque psoriasis during the current quarter.

IDERA PHARMACEUTICALS INC : Idera Pharmaceuticals Announces Closing ...

Tue, 07 May 2013 20:22:20 GMT

IDERA PHARMACEUTICALS INC : Idera Pharmaceuticals Announces Closing ...
4-traders (press release) - May 7, 2013

The gross proceeds to Idera Pharmaceuticals from this offering were $16.5 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Idera and excluding the proceeds, if any, from the exercise of ...

Stock Losers: Pike Electric Corporation(NYSE:PIKE), USEC Inc, Idera ... - SBWire (press release)

Idera Pharmaceuticals (IDRA) Releases Quarterly Earnings Results, Beats ...

Wed, 15 May 2013 13:16:30 GMT

Idera Pharmaceuticals (IDRA) Releases Quarterly Earnings Results, Beats ...
Mideast Time - May 15, 2013

Idera Pharmaceuticals, Inc. is engaged in the discovery and development of deoxyribonucleic acid (NASDAQ: IDRA) and ribonucleic acid (RNA)-based drug candidates targeted to Toll-Like Receptors (TLRs), to treat infectious diseases, autoimmune and ...

Idera reports smaller-than-expected net loss of Q1 - Boston Business Journal (blog)

Idera Pharmaceuticals Announces Pricing of Public Offering of Common Stock ...

Thu, 02 May 2013 13:36:52 GMT

Idera Pharmaceuticals Announces Pricing of Public Offering of Common Stock ...
DailyFinance - May 2, 2013

Idera Pharmaceuticals is a clinical stage biotechnology company engaged in the discovery and development of novel synthetic DNA- and RNA-based drug candidates that are designed to modulate immune responses mediated through Toll-like Receptors.

US/Canada daily earnings hits & misses May 15 - 1815 ET

Wed, 15 May 2013 12:01:45 GMT

US/Canada daily earnings hits & misses May 15 - 1815 ET
Reuters - May 15, 2013

... IDERA PHARMACEUTICALS INC Q1 BIOTECHNOLOGY USD -0.17 -0.15 0.02 0.0 0.0 0.0 INTERTAPE POLYMER Q1 UNDESIGNATED CAPITAL USD 0.21 0.24 0.03 196.9 196.7 -0.2 ISORAY INC Q3 MEDICAL SUPPLIES USD -0.03 -0.02 0.01 1.1 1.3 0.1 ...

Small companies squeezed in IPO surge

Mon, 13 May 2013 13:44:32 GMT

Small companies squeezed in IPO surge
The Deal Pipeline - May 13, 2013

The fully marketed secondary offerings that priced that week include Idera Pharmaceuticals Inc., which raised $17 million; Macquarie Infrastructure Co.

Research and Markets: Systemic Lupus Erythematosus - Pipeline Review, H1 ...

Wed, 24 Apr 2013 08:40:32 GMT

Research and Markets: Systemic Lupus Erythematosus - Pipeline Review, H1 ...
Wall Street Journal (press release) - Apr 24, 2013

... S.r.l. -- Eli Lilly and Company -- Genentech, Inc. -- Genesis Research and Development Corporation Ltd. -- GlaxoSmithKline plc -- Hadasit Medical Research Services & Development Lt -- IMMUNOMEDICS, INC -- Idera Pharmaceuticals, Inc. -- Immupharma ...

Nasdaq stocks posting largest volume increases

Mon, 06 May 2013 22:12:05 GMT

Nasdaq stocks posting largest volume increases
Businessweek - May 6, 2013

The shares remained unchanged at $45.42. Bluefly Inc. : Approximately 90,600 shares changed hands, a 803.9 percent increase over its 65-day average volume.

Idera Pharmaceuticals Inc Announces Closing Of Common Share Offering

Tue, 07 May 2013 20:15:00 GMT

Idera Pharmaceuticals Inc Announces Closing Of Common Share Offering
Reuters Key Development - May 7, 2013